These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 29291964)

  • 21. [The problem of radiogenic and chemotherapy-induced mucositis of the mouth and and oropharynx exemplified by accelerated radiochemotherapy with carboplatin in patients with inoperable squamous epithelial carcinomas of the head-/neck area. Heidelberg experiences].
    Dietz A; Nollert J; Maier H; Rudat V; Flentje M
    HNO; 1995 Jul; 43(7):403-13. PubMed ID: 7545657
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of extracts from indigowood root (Isatis indigotica Fort.) on immune responses in radiation-induced mucositis.
    You WC; Hsieh CC; Huang JT
    J Altern Complement Med; 2009 Jul; 15(7):771-8. PubMed ID: 19534614
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phenylbutyrate mouthwash mitigates oral mucositis during radiotherapy or chemoradiotherapy in patients with head-and-neck cancer.
    Yen SH; Wang LW; Lin YH; Jen YM; Chung YL
    Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):1463-70. PubMed ID: 21840136
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Benzydamine for prophylaxis of radiation-induced oral mucositis in head and neck cancers: a double-blind placebo-controlled randomized clinical trial.
    Kazemian A; Kamian S; Aghili M; Hashemi FA; Haddad P
    Eur J Cancer Care (Engl); 2009 Mar; 18(2):174-8. PubMed ID: 19267733
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prospective assessment of oral mucositis and its impact on quality of life and patient-reported outcomes during radiotherapy for head and neck cancer.
    Franco P; Martini S; Di Muzio J; Cavallin C; Arcadipane F; Rampino M; Ostellino O; Pecorari G; Garzino Demo P; Fasolis M; Airoldi M; Ricardi U
    Med Oncol; 2017 May; 34(5):81. PubMed ID: 28386836
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acute-phase response reactants as objective biomarkers of radiation-induced mucositis in head and neck cancer.
    Mohammed FF; Poon I; Zhang L; Elliott L; Hodson ID; Sagar SM; Wright J
    Head Neck; 2012 Jul; 34(7):985-93. PubMed ID: 21953802
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acute toxicities experienced during simultaneous integrated boost intensity-modulated radiotherapy in head and neck cancers--experience from a north Indian regional cancer centre.
    Chakraborty S; Ghoshal S; Patil V; Oinam A; Suresh S
    Clin Oncol (R Coll Radiol); 2009 Nov; 21(9):676-86. PubMed ID: 19748768
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phase 3 trial of domiciliary humidification to mitigate acute mucosal toxicity during radiation therapy for head-and-neck cancer: first report of Trans Tasman Radiation Oncology Group (TROG) 07.03 RadioHUM study.
    Macann A; Fua T; Milross CG; Porceddu SV; Penniment M; Wratten C; Krawitz H; Poulsen M; Tang CI; Morton RP; Hay KD; Thomson V; Bell ML; King MT; Fraser-Browne CL; Hockey HU
    Int J Radiat Oncol Biol Phys; 2014 Mar; 88(3):572-9. PubMed ID: 24521675
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Radiation doses to structures within and adjacent to the larynx are correlated with long-term diet- and speech-related quality of life.
    Dornfeld K; Simmons JR; Karnell L; Karnell M; Funk G; Yao M; Wacha J; Zimmerman B; Buatti JM
    Int J Radiat Oncol Biol Phys; 2007 Jul; 68(3):750-7. PubMed ID: 17418971
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Local reactions and complications (injuries) in the radiation therapy of malignant head and neck tumors. Their prevention and treatment].
    Vorob'ev IuI
    Med Radiol (Mosk); 1991; 36(3):50-2. PubMed ID: 2017007
    [No Abstract]   [Full Text] [Related]  

  • 31. [Immunoglobulin for prevention of radiogenic mucositis].
    Mose S; Adamietz IA; Thilmann C; Saran F; Heyd R; Knecht R; Böttcher HD
    HNO; 1995 Jul; 43(7):421-6. PubMed ID: 7672999
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and safety of subcutaneous amifostine in minimizing radiation-induced toxicities in patients receiving combined-modality treatment for squamous cell carcinoma of the head and neck.
    Law A; Kennedy T; Pellitteri P; Wood C; Christie D; Yumen O
    Int J Radiat Oncol Biol Phys; 2007 Dec; 69(5):1361-8. PubMed ID: 17869022
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of the Continuum of Radiation-Induced Normal Tissue Injury by a Redox-Active Mn Porphyrin.
    Birer SR; Lee CT; Choudhury KR; Young KH; Spasojevic I; Batinic-Haberle I; Crapo JD; Dewhirst MW; Ashcraft KA
    Radiat Res; 2017 Jul; 188(1):94-104. PubMed ID: 28517962
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phase II clinical trial of local use of GM-CSF for prevention and treatment of chemotherapy- and concomitant chemoradiotherapy-induced severe oral mucositis in advanced head and neck cancer patients: an evaluation of effectiveness, safety and costs.
    Mantovani G; Massa E; Astara G; Murgia V; Gramignano G; Lusso MR; Camboni P; Ferreli L; Mocci M; Perboni S; Mura L; Madeddu C; Macciò A
    Oncol Rep; 2003; 10(1):197-206. PubMed ID: 12469169
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of Patient Benefit From Proton Therapy for Advanced Head and Neck Cancer Patients Based on Individual and Subgroup Normal Tissue Complication Probability Analysis.
    Jakobi A; Bandurska-Luque A; Stützer K; Haase R; Löck S; Wack LJ; Mönnich D; Thorwarth D; Perez D; Lühr A; Zips D; Krause M; Baumann M; Perrin R; Richter C
    Int J Radiat Oncol Biol Phys; 2015 Aug; 92(5):1165-1174. PubMed ID: 26194685
    [TBL] [Abstract][Full Text] [Related]  

  • 36. RADIATION-INDUCED MUCOSITIS IN PATIENTS WITH HEAD AND NECK CANCER: SHOULD THE SIGNS OR THE SYMPTOMS BE MEASURED?
    Gussgard AM; Jokstad A; Hope AJ; Wood R; Tenenbaum H
    J Can Dent Assoc; 2015; 81():f11. PubMed ID: 26214833
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of low-level laser therapy in the prevention and treatment of radiation-induced mucositis: a double-blind randomized study in head and neck cancer patients.
    Carvalho PA; Jaguar GC; Pellizzon AC; Prado JD; Lopes RN; Alves FA
    Oral Oncol; 2011 Dec; 47(12):1176-81. PubMed ID: 21911312
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cancer treatment-induced oral mucositis: a critical review.
    Rodríguez-Caballero A; Torres-Lagares D; Robles-García M; Pachón-Ibáñez J; González-Padilla D; Gutiérrez-Pérez JL
    Int J Oral Maxillofac Surg; 2012 Feb; 41(2):225-38. PubMed ID: 22071451
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Therapeutic effect of recombinant human epidermal growth factor (RhEGF) on mucositis in patients undergoing radiotherapy, with or without chemotherapy, for head and neck cancer: a double-blind placebo-controlled prospective phase 2 multi-institutional clinical trial.
    Wu HG; Song SY; Kim YS; Oh YT; Lee CG; Keum KC; Ahn YC; Lee SW
    Cancer; 2009 Aug; 115(16):3699-708. PubMed ID: 19514089
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phase II double-blind randomized study comparing oral aloe vera versus placebo to prevent radiation-related mucositis in patients with head-and-neck neoplasms.
    Su CK; Mehta V; Ravikumar L; Shah R; Pinto H; Halpern J; Koong A; Goffinet D; Le QT
    Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):171-7. PubMed ID: 15337553
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.